Brevan Howard Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,777
Closed -$500K 1166
2024
Q4
$500K Buy
+9,777
New +$500K ﹤0.01% 591